EUVIMEDEUVIMED entdecken
Crossref

Clozapine shows benefit in first‐episode psychosis after one failed trial

The Brown University Psychopharmacology Update · 2026-07 · 37 (7) · 1-6

DOI: 10.1002/pu.31462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 29.05.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with first‐episode psychosis who were switched to clozapine after a failed antipsychotic trial saw greater improvement than those receiving olanzapine or amisulpride, a sequential trial has found. The results offer some evidence to counteract the common recommendation to initiate clozapine only after at least two failed antipsychotic trials. Study results were published online March 11, 2026 in JAMA Psychiatry .

Zitieren

APA

(2026). Clozapine shows benefit in first‐episode psychosis after one failed trial. The Brown University Psychopharmacology Update, 37(7), 1-6. https://doi.org/10.1002/pu.31462

Vancouver

Clozapine shows benefit in first‐episode psychosis after one failed trial. The Brown University Psychopharmacology Update. 2026;37(7):1-6. doi:10.1002/pu.31462

BibTeX
@article{euvimed2026,
  title = {Clozapine shows benefit in first‐episode psychosis after one failed trial},
  journal = {The Brown University Psychopharmacology Update},
  year = {2026},
  volume = {37},
  number = {7},
  pages = {1--6},
  doi = {10.1002/pu.31462}
}
Kostenlos starten →